Analysts Set National Health Investors, Inc. (NYSE:NHI) Target Price at $84.83

National Health Investors, Inc. (NYSE:NHIGet Free Report) has earned a consensus recommendation of “Buy” from the six brokerages that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $84.8333.

Several research firms have recently weighed in on NHI. Cantor Fitzgerald began coverage on shares of National Health Investors in a research report on Wednesday, October 1st. They set an “overweight” rating and a $90.00 price objective for the company. Truist Financial raised their price objective on shares of National Health Investors from $77.00 to $81.00 and gave the company a “buy” rating in a research report on Friday, August 15th. Wedbush upgraded shares of National Health Investors to a “strong-buy” rating in a research report on Wednesday, July 2nd. Weiss Ratings restated a “buy (b-)” rating on shares of National Health Investors in a research report on Wednesday, October 8th. Finally, KeyCorp upgraded shares of National Health Investors from a “sector weight” rating to an “overweight” rating and set a $80.00 price objective for the company in a research report on Thursday, July 10th.

Check Out Our Latest Analysis on NHI

Institutional Trading of National Health Investors

Hedge funds have recently bought and sold shares of the company. EverSource Wealth Advisors LLC lifted its stake in National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after buying an additional 288 shares in the last quarter. Smartleaf Asset Management LLC lifted its stake in National Health Investors by 49.8% during the first quarter. Smartleaf Asset Management LLC now owns 442 shares of the real estate investment trust’s stock valued at $33,000 after buying an additional 147 shares in the last quarter. Farther Finance Advisors LLC lifted its stake in National Health Investors by 5,000.0% during the first quarter. Farther Finance Advisors LLC now owns 918 shares of the real estate investment trust’s stock valued at $68,000 after buying an additional 900 shares in the last quarter. Assetmark Inc. lifted its stake in National Health Investors by 19.0% during the second quarter. Assetmark Inc. now owns 925 shares of the real estate investment trust’s stock valued at $65,000 after buying an additional 148 shares in the last quarter. Finally, NewEdge Advisors LLC lifted its stake in National Health Investors by 28.7% during the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after buying an additional 345 shares in the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Stock Performance

Shares of NHI opened at $75.20 on Friday. The firm has a 50-day moving average price of $77.13 and a 200 day moving average price of $74.23. The firm has a market capitalization of $3.57 billion, a PE ratio of 24.03, a P/E/G ratio of 3.39 and a beta of 0.77. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75. National Health Investors has a 52-week low of $65.13 and a 52-week high of $82.32.

National Health Investors (NYSE:NHIGet Free Report) last announced its earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.16 by $0.06. The firm had revenue of $70.27 million during the quarter, compared to analyst estimates of $86.46 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. National Health Investors’s revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.18 EPS. On average, sell-side analysts anticipate that National Health Investors will post 4.41 earnings per share for the current fiscal year.

National Health Investors Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.92 per share. This is a positive change from National Health Investors’s previous quarterly dividend of $0.90. The ex-dividend date is Tuesday, September 30th. This represents a $3.68 annualized dividend and a dividend yield of 4.9%. National Health Investors’s payout ratio is 117.57%.

National Health Investors Company Profile

(Get Free Report)

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

See Also

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.